Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JG.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JG.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JG.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.22ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.22NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.15ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.15ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.15ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.15NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HV.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
HV.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.58ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.58NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KQ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KQ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KQ.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.46ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.46NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used